Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.17 CAD | +8.50% |
|
+13.61% | -19.63% |
Jun. 05 | NervGen Pharma Corp. Approves Board and Audit Committee Elections | CI |
May. 16 | NervGen Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 140M 102M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.96% |
1 day | +3.50% | ||
1 week | +8.38% | ||
Current month | +6.15% | ||
3 months | -31.00% | ||
6 months | +27.78% | ||
Current year | -23.33% |
![Extreme 1.65](/images/extremecours_fleche.png)
![Extreme 1.65](/images/extremecours_fleche.png)
![Extreme 1.65](/images/extremecours_fleche.png)
![Extreme 1.58](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 0.8](/images/extremecours_fleche.png)
![Extreme 0.8](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Michael Kelly
CEO | Chief Executive Officer | 59 | 23-04-09 |
Bill Adams
DFI | Director of Finance/CFO | 62 | 20-02-23 |
Daniel Mikol
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Randall Kaye
BRD | Director/Board Member | 61 | 20-10-27 |
Brian Bayley
BRD | Director/Board Member | 71 | 18-05-15 |
Michael Kelly
CEO | Chief Executive Officer | 59 | 23-04-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 2.17 | +8.50% | 184 063 |
24-06-07 | 2 | +7.53% | 122,140 |
24-06-06 | 1.86 | +3.91% | 29,180 |
24-06-05 | 1.79 | -2.72% | 75,592 |
24-06-04 | 1.84 | -3.66% | 36,460 |
Delayed Quote Toronto S.E., June 10, 2024 at 09:46 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.33% | 102M | |
+45.94% | 57.87B | |
+40.54% | 40.25B | |
-6.66% | 39.94B | |
-5.16% | 28.54B | |
+10.86% | 26.4B | |
-20.27% | 19.33B | |
+30.53% | 12.4B | |
-1.09% | 12.23B | |
+22.67% | 12.2B |
- Stock Market
- Equities
- NGEN Stock